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Summary
Background: The aim of this study was to characterize coronary plaque composi-
tion of non-target lesions in diabetic patients using virtual histology intravascular
ultrasound (VH-IVUS).
Methods and results: In 134 stable angina pectoris patients, plaque components of
non-culprit (<50% in diameter stenosis) lesions in de novo target vessels were ana-
lyzed by VH-IVUS. Plaque characterization was compared between diabetic (n = 65)
and non-diabetic groups (n = 69). Diabetic patients were further divided into four
groups according to estimated glomerular ﬁltration rate (eGFR, ml/min): eGFR ≥70
(n = 20), 50≤ eGFR < 70 (n = 19), GFR < 50 (n = 18), and end stage renal disease (ESRD)
on hemodialysis (HD) (n = 11). There was no signiﬁcant difference in plaque composi-
tion between the diabetic and the non-diabetic patients except for the percentage of
dense calcium (8.9% vs. 6.2%; p < 0.05). In the diabetic patients, the percent volume
of necrotic core was 9.6%, 11.4%, 14.8%, and 20.8% in the eGFR ≥70, 50≤ eGFR < 70,
eGFR < 50, and the ESRD on HD groups, respectively, showing signiﬁcantly higher
percentage in eGFR < 50 (p < 0.05 vs. eGFR≥ 70) and ESRD on HD group (p < 0.001).
Conclusions: Diabetic patients have signiﬁcantly larger amount of dense calcium
than non-diabetic patients in non-culprit coronary artery segments, and the plaque
components of non-culprit lesions in diabetes are signiﬁcantly different according
to the decline in renal function.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
reserved.
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Introduction
Diabetes mellitus is associated with increased
cardiovascular event rates especially when compli-
cated by renal dysfunction [1]. There is a signiﬁcant
association between deteriorating renal function
and increasing coronary morbidity and mortal-
ity rates [2—4]. Even mild renal dysfunction has
been shown to have a signiﬁcant impact on the
clinical outcomes in diabetic patients [5,6]. Char-
acterization of plaque composition by intravascular
ultrasound (IVUS) has played an important role in
elucidating the atherosclerotic disease process in
human coronary arteries. Conventional gray scale
IVUS, however, is of limited value in analyzing
atherosclerotic plaque composition. Virtual his-
tology IVUS (VH-IVUS) uses spectral analysis of
IVUS radio frequency (RF) data, demonstrating
a potential to provide characteristics of plaque
composition as ﬁbrotic, ﬁbro-fatty, calciﬁed, and
necrotic core [7]. A previous study has shown the
feasibility of VH-IVUS for the analysis of plaque
characterization in diabetic patients [8]. How-
ever, the impact of renal function on coronary
atherosclerotic plaque composition has not been
fully elucidated. Hence, the aim of this study is
to evaluate the plaque composition of non-culprit
lesion in diabetic patients with early and advanced
renal impairment using VH-IVUS.
Methods
Study population
Between October 2005 and August 2007, non-culprit
angiographically non-obstructive (<50% in diameter
stenosis by angiography) lesions were investigated
with VH-IVUS in 134 consecutive stable angina pec-
toris (SAP) patients. SAP was deﬁned as no change in
the frequency, duration, or intensity of symptoms
within at least previous 6 weeks before interven-
tion. Diabetes was deﬁned as fulﬁlling either at
least one of the following: (1) Hemoglobin A1c more
than 6.4%; (2) patients treated with hypoglycemic
agents (insulin or oral hypoglycemic drugs). Dia-
betic patients were further divided into four groups
according to previously established categories [9]
and epidemiology of chronic kidney disease (CKD)
in Japan [10—12]: estimated glomerular ﬁltration
rate (eGFR) ≥70, 50≤ eGFR < 70, eGFR < 50, and
end stage renal disease (ESRD) on hemodialysis
(HD). The eGFR was calculated by modiﬁcation of
the diet in renal disease (MDRD) equation modiﬁed
by a Japanese coefﬁcient [12] using the base-
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ine serum creatinine. Chronic total occlusions and
stial lesions were excluded from this study.
VUS imaging and analysis
ll VH-IVUS examinations were performed before
cheduled coronary intervention. A 20MHz, 3.2Fr,
H-IUVS catheter (Eagle EyeTM Gold, Volcano Cor-
oration, Rancho Cordova, CA, USA) was pulled
ack automatically at a rate of 0.5mm/s. We
eﬁned the non-culprit lesion as angiographi-
ally non-obstructive (<50% in diameter stenosis)
mm segment more than 5mm proximal to the
ulprit lesion. Quantitative measurements were
erformed according to American College of Car-
iology Clinical Expert Consensus Document on
VUS [13]. As previously described [14], coronary
laque was classiﬁed into four different compo-
ents (IVUSLab software, Volcano Corporation):
brous was shown in green, ﬁbro-fatty in greenish
ellow, dense calcium in white, and necrotic core in
ed. Volumetric measurements were performed by
racing the external elastic membrane and lumen
order, and the volumetric value of each plaque
omponent was automatically calculated.
tatistical analysis
tatistical analyses were performed using StatView
SAS Institute, Cary, NC, USA). Quantitative data
re presented as mean± S.D.. Continuous variables
ere compared by unpaired Student’s t-test or
ann—Whitney U-statistic test. Categorical vari-
bles (presented as frequencies) were compared
sing chi-square statistics or Fisher’s exact prob-
bility test. Comparisons among the four groups
ere performed by analysis of variance (ANOVA)
or independent samples and the chi-square test for
omparison of categorical variables. A p < 0.05 was
onsidered statistically signiﬁcant for all analyses.
esults
aseline clinical characteristics of the diabetic
roup and the non-diabetic group are presented in
able 1. All diabetic patients had type 2 diabetes.
he values of fasting blood glucose, glycosylated
emoglobin, and C-reactive protein (CRP) in the
iabetic group were signiﬁcantly higher than those
n the non-diabetic group. Glomerular ﬁltration
ate in diabetes was signiﬁcantly lower than that in
on-diabetes. There was no signiﬁcant difference
etween the groups in other parameters.
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Table 1 Clinical characteristics of all patients.
DM (n = 65) Non-DM (n = 69) p-value
Age 66± 8 67± 8 0.21
Gender (female) (n, %) 10 (15.4) 16 (23.2) 0.25
Diabetes mellitus
Insulin (n, %) 5 (11.9)
OHA (n, %) 12 (28.6)
Hypertension (n, %) 40 (61.5) 45 (65.2) 0.66
Hyperlipidemia (n, %) 41 (63.1) 48 (69.6) 0.43
Smoking (n, %) 43 (66.2) 43 (62.3) 0.64
Target lesion
LAD (n, %) 26 (40.0) 37 (53.6)
LCX (n, %) 17 (26.1) 10 (14.5) 0.16
RCA (n, %) 22 (33.8) 22 (31.9)
FBG (mg/dl) 127± 30 104± 11 <0.001
HbA1c (%) 7.0± 1.3 5.5± 0.5 <0.001
T. Chol (mg/dl) 184± 42 194± 29 0.13
HDL (mg/dl) 44± 10 47± 9 0.09
LDL (mg/dl) 113± 39 113± 24 0.93
TG (mg/dl) 141± 61 135± 60 0.56
CRP (mg/dl) 0.45± 0.54 0.26± 0.48 0.04
GFR (ml/min) 54.3± 26.6 64.1± 17.9 0.01
OHA, oral hypoglycemic agents; LAD, left anterior descending artery; LCX, left circumﬂex artery; RCA, right coronary artery;
FBG, fasting blood glucose; HbA1c, hemoglobin A1c; T. Chol, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL,
-reac
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subjects is shown in each group in brackets. Values are means
Table 2 shows IVUS results comparing the dia-
etic group (DM) and the non-diabetic group
Non-DM). There was no signiﬁcant difference in
he volume parameters by grey-scale IVUS between
he two groups. With regard to VH-IVUS, no signiﬁ-
ant difference in plaque composition was observed
xcept for signiﬁcantly larger dense calcium in dia-
etic patients.
The baseline characteristics of the four sub-
roups divided by renal function in the diabetic
i
s
t
a
Table 2 Overall IVUS characteristics.
DM (n = 65)
Gray-scale IVUS
EEM volume (mm3) 88.1 ± 28.2
Plaque volume (mm3) 50.1 ± 15.4
Lumen volume (mm3) 39.7 ± 17.4
VH-IVUS
Fibrous (%) 64.1 ± 12.4
Fibro-fatty (%) 13.6 ± 9.5
Dense calcium (%) 8.9 ± 7.8
Necrotic core (%) 13.2 ± 8.1
IVUS, intravascular ultrasound; EEM, external elastic membrane; VH
of subjects is shown in each group in brackets. Values are means±tive protein; GFR, glomerular ﬁltration rate. The number of
.
roups are shown in Table 3. The results show lower
holesterol levels and higher CRP values in the
ialysis patients. The comparison of IVUS analysis
mong diabetic patients according to renal function
s shown in Table 4. Dense calcium was signiﬁ-
antly larger in the ESRD on HD group. As shown
n Figs. 1 and 2, the plaque composition showed a
igniﬁcant difference according to the renal func-
ion. The percent volume of necrotic core showed
stepwise increase in more advanced stages of
Non-DM (n = 69) p-value
90.1 ± 32.3 0.71
47.2 ± 15.9 0.28
42.9 ± 19.8 0.33
65.6 ± 10.5 0.46
16.5 ± 9.7 0.08
6.2 ± 6.7 0.03
11.2 ± 7.1 0.13
-IVUS, virtual histology-intravascular ultrasound. The number
S.D.
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Table 3 Clinical characteristics in diabetes according to the renal function.
eGFR >70 (n = 20) eGFR 50—70 (n = 19) eGFR <50 (n = 18) HD (n = 11) p-value
Age 66.9± 8.2 66.5± 8.3 69.8± 6.9 66.6± 7.8 0.45
Gender (female) (n, %) 7 (16.7) 10 (38.5) 6 (23.1) 3 (11.5) 0.73
Hypertension (n, %) 30 (71.4) 34 (59.6) 15 (68.2) 6 (46.2) 0.33
Hyperlipidemia (n, %) 30 (71.4) 39 (68.4) 14 (63.6) 6 (46.2) 0.38
Smoking (n, %) 29 (69.0) 39 (68.4) 10 (45.5) 8 (61.5) 0.23
Target lesion
LAD (n, %) 14 33 12 4
LCX (n, %) 7 10 6 4 0.06
RCA (n, %) 21 14 4 5
HbA1c (%) 6.5± 1.6 5.9± 0.7 6.4± 0.8 6.7± 1.6 0.03
T. Chol (mg/dl) 194.7± 25.3 199.3± 28.2 175.4± 34.9 144.0± 5.7 0.02
HDL (mg/dl) 44.1± 8.2 49.4± 9.5 44.6± 9.4 37.0± 12.7 0.06
LDL (mg/dl) 132.5± 44.5 104.8± 36.0 111.5± 27.6 96.5± 36.2 0.04
TG (mg/dl) 137.5± 58.1 124.5± 47.9 145.3± 41.3 171.2± 95.7 0.24
CRP (mg/dl) 0.26± 0.31 0.23± 0.21 0.66± 0.73 0.87± 0.69 0.001
LAD, left anterior descending artery; LCX, left circumﬂex artery; RCA, right coronary artery; HbA1c, hemoglobin A1c; T. Chol, total
cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglycerides; CRP, C-reactive
protein. The number of subjects is shown in each group in brackets. Values are means± S.D.
Table 4 IVUS analysis in diabetes according to renal function.
eGFR >70 (n = 20) eGFR 50—70 (n = 19) eGFR <50 (n = 18) HD (n = 11) p-value
Gray-scale IVUS
EEM volume (mm3) 87.8 ± 25.6 93.6 ± 29.6 91.2 ± 32.2 75.1 ± 23.3 0.36
Plaque volume (mm3) 47.3 ± 14.1 52.3 ± 16.9 52.0 ± 16.7 48.9 ± 13.9 0.73
Lumen volume (mm3) 40.5 ± 13.4 41.2 ± 20.3 39.4 ± 17.7 35.7 ± 20.1 0.86
VH-IVUS
Fibrous (%) 65.8 ± 10.4 68.1 ± 10.2 66.3 ± 6.7 51.5 ± 17.9 0.002
Fibro-fatty (%) 18.7 ± 12.0 13.1 ± 6.4 11.4 ± 9.0 8.2 ± 4.6 0.014
Dense calcium (%) 5.8 ± 5.4 7.1 ± 4.9 7.4 ± 3.0 19.6 ± 10.8 <0.0001
Necrotic core (%) 9.6 ± 7.3 11.4 ± 5.3 14.8 ± 4.9 20.8 ± 11.6 0.0008
IVUS, intravascular ultrasound; EEM, external elastic membrane; VH-IVUS, virtual histology-intravascular ultrasound. The number
of subjects is shown in each group in brackets. Values are means± S.D.
Figure 1 Comparison of the area of necrotic core in diabetic patients. Values are means± S.D. The percent area of
necrotic core was 14.3% and 20.8% in the estimated glomerular ﬁltration rate (eGFR) <50 group and the end stage
renal disease (ESRD) on hemodialysis (HD) group, respectively, values signiﬁcantly higher than 9.6% in the eGFR ≥70
group (p < 0.05 and p = 0.001).
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Figure 2 Comparison of the percent area of ﬁbro-fatty in diabetic patients with renal sufﬁciency in four groups.
Values are means± S.D. Higher percent area of ﬁbro-fatty was observed in milder renal impairment group, namely,
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p8.7% in the estimated glomerular ﬁltration rate (eGFR) ≥
GFR <50 group and the end stage renal disease (ESRD) on
enal dysfunction. Conversely, higher percent vol-
me of ﬁbro-fatty plaque was observed in higher
GFR group.
iscussion
iabetic patients had signiﬁcantly larger dense cal-
ium than non-diabetic patients in the present
tudy. Our results also showed that VH-IVUS-deﬁned
ecrotic core was more frequently observed
ccording to the decline in renal function in dia-
etic patients.
In our study, we found that dense calcium was
igniﬁcantly larger in the diabetic group than that
n non-diabetics. Nasu et al. reported that dia-
etic patients had greater amounts of necrotic core
nd dense calcium than non-diabetic patients in
ulprit lesions of stable angina pectoris patients [8].
ur data on dense calcium in non-culprit lesions
re compatible with their data, suggesting that the
therosclerotic process is not conﬁned to the cul-
rit lesion, but similar changes could be observed
n other parts of coronary artery segments.
Both dense calcium and necrotic core was sig-
iﬁcantly larger in HD group than non-HD group.
previous gray scale IVUS study has shown thatemodialysis patients have larger lesion plaque
ass and more lesion site calciﬁcation [9]. In the
resent imaging modality including EBCT, MDCT,
ray scale IVUS, and VH-IVUS, it is difﬁcult to distin-
uish between intimal atherosclerotic calciﬁcation
d
n
i
aroup was signiﬁcantly higher than 11.4% and 8.2% in the
odialysis (HD) group, respectively (p < 0.05 and p < 0.01).
nd medial calciﬁcation related to dialysis which
ontributes to VH-IVUS derived calcium [15—18].
urther studies will be needed to clarify the impact
f dialysis and atherosclerosis on vascular calciﬁ-
ation. We observed a larger amount of necrotic
ore in the dialysis group; however, this result needs
o be interpreted with caution. Since VH-IVUS was
eported to have difﬁculty distinguishing necrotic
ore from calciﬁcation in the initial study [7], this
esult may suggest either the presence of higher
ercentage of necrotic tissue, or possible artifacts
y increased amount of calcium in such patients.
CKD has become a major health care problem
nd it has been well-established that CKD is asso-
iated with higher mortality due to coronary artery
isease rather than progress to ESRD [2]. Coronary
rtery calciﬁcation (CAC) is an independent pre-
ictor of coronary artery disease. Several previous
tudies using electron beam computed tomography
nd autopsy, have demonstrated that extensive CAC
evelops in patients with CKD even before initiating
ialysis [19,20]. Kramer et al. demonstrated that
iabetic patients even without nephropathy had
igher CAC score than non-diabetic CKD patients,
nd furthermore, among patients with diabetes,
he more advanced stage of CKD greatly impacted
he prevalence of CAC [21]. Several VH-IVUS studies
ave been reported with regard to the plaque com-
osition in human coronary arteries. As previously
escribed, diabetic patients had greater amounts of
ecrotic core and dense calcium than non-diabetics
n culprit lesions of SAP [8]. Rodriguez-Granillo et
l. [22] reported that VH-derived necrotic core in
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non-culprit lesion was signiﬁcantly higher in acute
coronary syndrome compared with SAP. However,
VH-IVUS in CKD patients has not been systematically
investigated.
In the present study, VH-IVUS-derived plaque
composition was signiﬁcantly different according to
the deterioration of renal function. Increase in the
percentage of VH-derived necrotic core and dense
calcium was observed even in the mild renal insuf-
ﬁciency group (11.4% and 7.1% in 50≤ eGFR < 70).
Our result is similar to that of a previous VH-IVUS
study examining culprit lesions in diabetic SAP [8].
The percentage of VH-derived necrotic core was
almost identical to another report on non-culprit
lesions of acute coronary syndrome, which showed
12.3% of necrotic core. The percentage of necrotic
core is increased [22] in the non-culprit lesion even
in the early stage of renal insufﬁciency, suggesting
that even mild renal impairment may signiﬁcantly
affect the plaque component in diabetic patients.
It has been reported that mild renal insufﬁciency
is associated with cardiovascular morbidity and
mortality, and several potential explanations are
provided for the excess cardiovascular risk in mild
renal dysfunction [1,23]. Our study suggests that
declining renal function strongly affects plaque
composition on diabetic patients. In view of the
signiﬁcantly greater risk for cardiovascular events
in diabetic patients with renal insufﬁciency, vigor-
ous coronary risk control may be indicated for such
patients.
Limitations
This is a single-center study with a small number
of patients, thus posing a risk for possible selection
bias. The observation was done only in the vessel
treated by PCI. In the present study, we deﬁned
the non-culprit lesion as 5mm length analyzing
by VH-IVUS, which comprises only a small part of
the entire coronary arteries. A recent report sug-
gests the plaque component identiﬁed by VH-IVUS
may not correlate well with histological observa-
tion [24]. Our results may not correctly reﬂect the
histological difference in vivo. There are several
inherent limitations in volumetric analysis tech-
niques as previously described [25].Conclusions
Our study suggests that diabetic patients have sig-
niﬁcantly larger amount of dense calcium than
non-diabetic patients in non-culprit coronary artery
[M. Ogita et al.
egment and declining renal function strongly
ffects plaque composition in diabetic patients.
ven mild renal impairment may signiﬁcantly affect
he plaque component. Further study is needed
o elucidate the mechanism of how renal function
ffects the atherosclerotic process.
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